Introducing [Beihe] Labetalol Hydrochloride Tablets, a precision-formulated medication designed to address a spectrum of cardiovascular conditions. Packaged in a convenient 30-tablet box, each tablet contains 50mg of labetalol hydrochloride, tailored to meet the therapeutic needs of patients suffering from hypertension, angina pectoris, hypertensive eclampsia, pheochromocytoma, and related conditions.
Effectively manages high blood pressure, reducing the risk of heart attacks, strokes, and kidney damage by relaxing blood vessels and improving blood flow.
By decreasing heart rate and cardiac output, [Beihe] Labetalol alleviates the symptoms of angina, enhancing quality of life for patients with coronary artery disease.
Essential in managing severe pregnancy-induced hypertension, [Beihe] Labetalol helps to control seizures and stabilize vital signs in at-risk mothers.
Controls the surge of adrenaline-like hormones produced by this rare tumor, aiding in blood pressure regulation during surgical interventions or long-term
In specific clinical scenarios, [Beihe] Labetalol can be utilized to carefully manage blood pressure, even in patients prone to low blood pressure, under close medical supervision.
Its ability to moderate the body's stress response contributes to reducing pain associated with certain cardiovascular emergencies.
[Beihe] Labetalol Hydr Tablets exert their therapeutic effects through a dual mechanism: blocking beta-adrenergic receptors, which slows the heart rate and decreases cardiac output, and alpha-1 adrenergic receptor blockade, which dilates blood vessels, further lowering blood pressure. This combined action provides comprehensive cardiovascular support.